THE INFLUENCE OF ONCE-MONTHLY RIFAMPICIN AND OF DAILY CLOFAZIMINE ON THE PHARMACOKINETICS OF DAPSONE IN LEPROSY PATIENTS

被引：0
|
作者：
ZUIDEMA, J [1 ]
PIETERS, F [1 ]
机构：
[1] UNIV AMSTERDAM,DEPT BIOPHARMACEUT,AMSTERDAM,NETHERLANDS
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 27卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：708 / 708
页数：1
相关论文
共 50 条
  • [31] Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic
    Samtani, Mahesh N.
    Vermeulen, An
    Stuyckens, Kim
    CLINICAL PHARMACOKINETICS, 2009, 48 (09) : 585 - 600
  • [32] The effects of aripiprazole once-monthly on the PANSS Marder factors in the treatment of patients with schizophrenia
    Baker, R. A.
    Eramo, A.
    Tsai, L. F.
    Peters-Strickland, T.
    Sanchez, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S541 - S541
  • [33] A candidate-identification questionnaire for patients with postmenopausal osteoporosis switched from treatment with a daily or weekly bisphosphonate to once-monthly ibandronate
    Kutsal, Y. Gokce
    Eskiyurt, N.
    Irdesel, J.
    Sepici, V.
    Ugurlu, H.
    Kirazli, Y.
    Ardic, F.
    Korsic, M.
    Vlak, T.
    Grlickov, M.
    Temelkova, S. M.
    Lazarov, M.
    Pilipovic, N.
    Popovic, V.
    Dimic, A.
    Kovacev, B.
    Ruci, D.
    Tafaj, A.
    Kucukalic-Selimovic, E.
    Avdic, D.
    Seleskovic, H.
    Pejicic, S.
    Butun, B.
    Akyuz, G.
    Cerrahoglu, L.
    Sendur, O. F.
    Yalcin, P.
    Oncel, S.
    Saridogan, M.
    Sarpel, T.
    Tosun, M.
    Senel, K.
    Gursoy, S.
    Canturk, F.
    Demir, H.
    Miskic, B.
    Krpan, D.
    Skreb, F.
    Grazio, S.
    Crncevic-Orlic, Z.
    Ozdener, F.
    Oncel, H.
    BONE, 2011, 48 : S233 - S234
  • [34] Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration
    Raoufinia, Arash
    Peters-Strickland, Timothy
    Nylander, Anna-Greta
    Baker, Ross A.
    Eramo, Anna
    Jin, Na
    Bricmont, Patricia
    Repella, Jennifer
    McQuade, Robert D.
    Hertel, Peter
    Larsen, Frank
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2017, 20 (04): : 295 - 304
  • [35] Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with SchizophreniaA Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic
    Mahesh N. Samtani
    An Vermeulen
    Kim Stuyckens
    Clinical Pharmacokinetics, 2009, 48 : 585 - 600
  • [36] Influence of baseline patient characteristics on response to once-monthly and daily oral ibandronate therapy: 2-year findings from mobile
    Reginster, J. Y.
    Hawker, G.
    Bolognese, M.
    Coutant, K.
    Hughes, C.
    Sedarati, F.
    Stone, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 426 - 426
  • [37] A CONTROLLED THERAPEUTIC TRIAL IN PAUCIBACILLARY LEPROSY COMPARING A SINGLE DOSE OF RIFAMPICIN WITH A SINGLE DOSE OF RIFAMPICIN FOLLOWED BY ONE YEAR OF DAILY DAPSONE
    PATTYN, SR
    GROENEN, G
    JANSSENS, L
    KUYKENS, L
    MPUTU, LB
    LEPROSY REVIEW, 1991, 62 (02) : 179 - 185
  • [38] HEPATITIS IN LEPROSY PATIENTS TREATED BY A DAILY COMBINATION OF DAPSONE, RIFAMPIN, AND A THIOAMIDE
    CARTEL, JL
    MILLAN, J
    GUELPALAURAS, CC
    GROSSET, JH
    INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 1983, 51 (04) : 461 - 465
  • [39] ONCE-MONTHLY PALIPERIDONE PALMITATE COMPARED WITH ORAL ATYPICAL ANTIPSYCHOTIC TREATMENT IN PATIENTS WITH SCHIZOPHRENIA
    Kim, E.
    Starr, H. L.
    Bossie, C.
    Mao, Lian
    Alphs, L.
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S318 - S318
  • [40] EFFECTS OF CLOFAZIMINE ALONE OR COMBINED WITH DAPSONE ON NEUTROPHIL AND LYMPHOCYTE FUNCTIONS IN NORMAL INDIVIDUALS AND PATIENTS WITH LEPROMATOUS LEPROSY
    VANRENSBURG, CEJ
    GATNER, EMS
    IMKAMP, FMJH
    ANDERSON, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (05) : 693 - 697
12345